Lv2
150 积分 2023-01-12 加入
Identification of a Broadly Fibrogenic Macrophage Subset Induced by Type 3 Inflammation in Human and Murine Liver and Lung Fibrosis
5小时前
已完结
Insights into immune cell–fibroblast communication in heart disease
3天前
已完结
Chromatin remodelling drives immune cell–fibroblast communication in heart failure
3天前
已完结
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
13天前
已完结
BiTE therapy for rheumatic diseases
15天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
15天前
已完结
Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches
15天前
已完结
Intravenous cyclophosphamidevsrituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial
15天前
已完结
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial
15天前
已完结
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
15天前
已完结
皖公网安备34019202002308
